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Introduction. Quantitative Ultrasound (QUS) measurement at the calcaneum is a 
convenient, cost effective and noninvasive method of determining bone strength well suited 
to community-based research in countries with limited resources. Although only moderately 
correlated with dual X-ray absorptiometry (DEXA) measurement of bone mineral density 
(BMD) at the hip and spine, quantitative ultrasound has shown to be a reliable predictor of 
osteoporotic fracture. This study aims to evaluate the use of QUS in epidemiological studies 
in South African settings. To this end, this report determines whether characteristics 
associated with QUS measures of bone strength in a large sample of premenopausal South 
African women are similar to those known to be associated with the BMD as measured by 
DEXA,  and compares these associations with those in other populations. 
Methods. This cross-sectional study included 3493 black and mixed race women aged 18 - 
44 living in Cape Town. Trained study nurses administered structured interviews on 
reproductive history and lifestyle factors. In addition they took height, weight and calcaneal 
QUS measurements using the Sahara device. Adjusted means of QUS measures according to 
categories of risk factors were obtained using multivariable regression analysis. 
Results. In both groups associations between QUS measures and age, Body Mass Index 
(BMI), age at menarche, parity and primary school physical activity were similar to those 
known to be associated with BMD as measured by DEXA. There were no clear associations 
between QUS and educational level, alcohol use, cigarette smoking, and current calcium 
intake.  
Conclusion.  The data give support to the use of QUS as an epidemiological tool in large 
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Osteoporosis is a skeletal disorder characterized by low bone mass and micro-architectural 
deterioration with subsequent bone fragility which commonly results in  fractures of the 
spine, hip or wrist. (Hans and  Krieg, 2008). Approximately 200 million people are affected 
world wide (Nayak et al., 2006) and thus osteoporosis has been identified by the World 
Health Organization (WHO) as a priority health issue (WHO, 2003). Currently, the WHO 
diagnosis of osteoporosis rests on the evaluation of bone mineral density (BMD) by Dual X-
ray absorptiometry at the hip and the lumbar spine. Dual X-ray absorptiometry (DEXA) is 
the most accurate of commonly available instruments for measuring BMD in clinical settings 
such as hospitals in urban centers.  
An alternative method for measuring bone quality is Quantitative Broadband Ultrasound 
(QUS). QUS standard equipment measures bone quality at the calcaneum but not at the 
lumbar spine or hip – the latter two anatomical sites most commonly involved in debilitating 
osteoporotic fracture. However QUS is significantly cheaper than DEXA and noninvasive, 
and the machine is readily portable making it a practical tool for large epidemiological 
investigations, particularly in community settings. In resource-limited countries like South 
Africa, it would be highly desirable to be able to use the more portable and cheaper 












2.1 Bone health and peak bone mass   
Growth in bone size and strength occurs during childhood and early adolescence, but bone 
accumulation is not completed until the third decade of life, long after linear growth has 
ceased due to closure of the long bone epiphyses. The age of peak bone mass is however 
considered to be variable and is affected by environmental factors (Micklesfield  et al., 
2005). The bone mass attained early in life is perhaps the most important determinant of life-
long skeletal health. Thus individuals with the highest peak bone mass after adolescence have 
the greatest protective advantage against the decrease in BMD associated with increasing 
age, illness, and diminished sex-steroid production. Maximizing bone mass early in life 
presents a critical opportunity to reduce the impact of bone loss related to aging (NIH 
Concensus Development Panel, 2001).  
Genetic factors exert a predominant influence on peak bone mass, but physiological, 
environmental, and modifiable lifestyle factors can also play a significant role. Among these 
are adequate nutrition and body weight, exposure to sex hormones at puberty, and physical 
activity. Adult bone mass may also be related to fracture occurrence in childhood and 
adolescence. 
Research indicates that reliable predictors of low bone mass are age, female gender, 
oestragen deficiency, low weight or BMI, white race, family history of osteoporosis, history 
of prior fracture, smoking and late menarche. Inconsistent predictors are: use of carbonated 
drinks or caffeine beverages and childhood physical activity (ibid). Impaired absorption or 
low dietary intake of Vitamin D and calcium, and excessive use of alcohol and tobacco are 











unclear (Moyad, 2003). In contrast, grip strength and current high impact physical activity  
are  associated with increased bone mass (NIH Concensus Development Panel, 2001). Most 
of these findings are from studies of post-menopausal women, and the relative importance of 
these factors in premenopausal women is not as well understood (Tudor-Locke and McColl, 
2000).   
2.2 Measurement technologies for bone strength 
The definition of osteoporosis as fragility of bone leading to fracture does not include 
diagnostic criteria. The operational definition developed by the WHO is in terms of bone 
mineral density (BMD) assessment and dual-energy x-ray absorptiometry (DEXA) is 
considered to be the most widely validated technology for this assessment (WHO, 2004). 
Osteoporosis is diagnosed in terms of standard deviations away from a healthy adult 
reference population (30 yrs) and is defined as 2.5 or more standard deviations (T- scores) 
below this mean (WHO, 2004). The primary focus on hip BMD, specifically at the femoral 
neck, is because this is the most common fracture site and the greatest morbidity associated 
with osteoporotic fracture is from fracture of the neck of femur.   
DEXA is commonly available for measuring BMD in clinical settings such as hospitals, 
however it involves the use of radiation, is expensive and is usually only situated  in urban 
centers. An alternative method for measuring bone quality is Quantitative Broadband 
Ultrasound (QUS). The correlation between heel QUS measures and heel BMD as measured 
by DEXA is fairly high (0.82 – 0.85: Sahara Users Guide; Hologic, 1998).  
It is well established that the QUS parameters Broadband Ultrasound Attenuation (BUA) and 
Speed of Sound (SOS) are associated with overall bone strength – reports demonstrate 











is related not only to bone density but also to macro - and micro-architecture and bone 
turnover (ibid) and QUS is thought to measure these bone qualities in addition to BMD 
(Gluer 2008). Specific aspects of micro-architecture that QUS is thought to measure include 
the number, thickness and orientation of trabeculae, and the elasticity of bone (Kroke et al., 
2000, Gregg et al., 1999, Toyras et al., 1999).    
2.3 Quantitative ultrasound   
The Sahara Ultrasound device measures two parameters: Speed of sound (SOS) in m/s, and 
Broadband ultrasonic attenuation (BUA, dB/MHZ).  SOS is the distance between the two 
transducers divided by the time it takes for the signal to pass from one transducer through the 
heel to the opposite transducer.    BUA is the slope the regression line for the relationship 
between the ultrasound attenuation and the sound frequency over the range 0.1 to 1 MHZ. 
(McClean et al., 2000). Higher values of BUA and SOS are associated with greater bone 
mass. The quantitative ultrasound index (QUI) or stiffness index is a linear combination of 
both BUA and SOS (QUI = (BUA + SOS) x 0.41 - 571).  Heel QUI is highly correlated with 
heel BMD as measured by DEXA (Hologic, 1998, Prins et al., 1998, Grampp et al., 1997) 
Different types of QUS (dry and water based) report different parameters which has made it 
difficult to validate QUS technology and the official position of the International Society for 
Clinical Densitometry (ISCD) is that  BMD from different types of QUS devices cannot be 
compared.  The ISCD recommend using BUA and SOS and the QUI, the so-called stiffness 
index, if necessary (Krieg M-A et al., 2008). 
2.4 QUS precision and accuracy 
Good quality measurements need to be both accurate and precise. Accuracy is the degree of 











a measurement. Translated into clinical terms, QUS must be sufficiently accurate to correctly 
discriminate between healthy and osteoporotic subjects.  Precision, also called repeatability, 
is defined as the degree to which repeated measurements show the same or similar results. 
Poor precision adds random error to results and detracts from the ability of the measurement  
to be used for monitoring purposes.  For the Sahara QUS device, results from 6 studies on 
short term precision measured by the coefficients of variation for BUA, SOS and QUI were 
as follows.  BUA:  Mean = 4.1% (Range 2.7 – 5.0), SOS: Mean =  0.3% (Range 0.2 - 0.4) 
and QUI: Mean = 2.6 % (Range 1.6 – 3.5) (Krieg M-A et al., 2008). 
To maximize precision  of QUS measurements  when carrying out  bone status assessment 
the quality control (QC) practices are a critical aspect  because changes due to osteoporosis 
or its treatment are very small.  As a first point of departure, the same subject should always 
be measured on the same machine. The complexity of the QC process will depend on 
whether the measurement is for a single study site or for a multi-center trial (Langton and 
Njeh, 2008). 
Factors affecting precision 
The Sahara QUS system is affected by  body positioning, temperature and soft tissue 
properties as well as aging of the system components, specifically the phantom used in daily 
QC checks and the transducer pads.  
Positioning of the foot is probably the major contributor to clinical imprecision. (Langton  
and Njeh, 2008) To obtain a precise result, anatomically consistent regions of bone must be 
measured. For sequential measurements used in individual monitoring, precision will be 












Precision of QUS can be affected by the temperature of both the environment and of the 
subject’s limb. Peripheral temperature of skin at the calcaneum can be low, substantially 
lower than core body temperature especially in the colder months. Studies have shown that 
SOS varies significantly with temperature (Ikeda and Iki 2004, Pocock et al., 2000). Over a 
range from 15 – 40 degrees Celsius, a strong negative correlation was demonstrated between 
temperature and SOS (Pocock et al, 2000). Specifically, a one degree Celsius increase in 
temp was shown to be associated with a 3.6 m/s drop in SOS (Krieg M-A et al., 2008). BUA 
was more stable, but nonetheless did show a small positive correlation with increased 
temperature (Pocock et al, 2000). These opposite associations for BUA and SOS with 
temperature make it difficult to interpret the mechanism behind the fluctuations. From a 
practical standpoint, it is recommended  that the temperature of the examination room  
should be between 20 and 27 degrees C (Sahara Hologic Guide, 1998) and  that the subjects 
foot should be warmed if necessary prior to taking the QUS measurement (Krieg M-A et al., 
2008). 
Transmission of  SOS  is similar in soft tissue and in trabecular bone. However inaccuracies 
of  SOS and BUA caused by variation in composition and thickness of soft tissues can be 
significant in longitudinal studies. Thus if the amount or consistency of the soft tissue around 
the heel varies within an individual between measurements this can influence measurement 
precision.  A 6mm increase in heel soft tissue thickness due to oedema was shown to result in 
a drop of 24 m/s in SOS (ibid) and a similar reduction in BUA was demonstrated in the 













Monitoring QUS precision  
The daily use of the manufacturer – specific phantoms is the principal method of detecting 
malfunction in the Sahara device resulting from aging of the transducer pads, inadequacy of 
the coupling path or electrical failure at any point in the circuitry. 
The properties of the phantoms do change with age and their reliability is temperature 
dependant. A conservative acceptable range for the daily phantom QC is provided by the 
manufacturers to allow operators to check the performance of the system.  
The daily QC process generates two measurements: Quality Assurance Broadband 
Attenuation (QAB) and Quality Assurance Speed of Sound (QAS ). These reflect the 
phantom properties as well as the machine operation and are influenced by the temperature of 
the room.  QAB and QAS equal the measured phantom BUA and SOS divided by the actual 
phantom BUA and SOS that was entered at the point of manufacture. Thus, in terms of 
instrument performance, theoretically QAB and QAS measurements would equal 1.00 if 
instrument precision was 100%. However the ultrasonic properties of the phantom due to 
temperature are more variable than the short term precision of the Sahara (Hologic User 
Guide, 1998). Because of this, daily fluctuations for these QAB and QAS would occur even 
if the Sahara system functioned with zero variation. According to the manufacturer, if the 
machine passes its QC test, it is performing within its specifications. In-built precautions are 
such that readings beyond the limits of 1.13 or 0.87 for QAB and 1.013 or 0.987 for QAS 
cause the machine to default to “Repeat QC in one hour” to allow for stabilization of the 
phantom temperature. Subsequent failure to pass the QC indicates a malfunction of the 











over time indicate that either the machine function or the condition of the phantom is sub-
optimal, with the possible loss of precision for QUS output (Hologic User Guide, 1998).        
Measuring individual versus measuring large groups   
Effective monitoring of bone status over time in an individual depends on the precision of the 
instrument as well as the magnitude of the expected change – which will in turn depend on 
the bone status of the individual concerned. 
Thus, for 2 single measurements over time in an individual, the variation between the 
measurements will be the sum of the true variation within the individual and the variation 
due to measurement error:  
Vtotal = Verror + V within individual 
With single measurements it is not possible to distinguish between the true difference and 
random error. If the random error of the instrument is known to be larger than the magnitude 
of the true expected change, the instrument cannot be used for this purpose.  According to the 
manufacturer (Hologic, Users Guide 199) the Sahara precision error for BMD is 0.014g.cm
2
. 
This is equivalent to 2.4 times the annual rate of loss in the US reference population (given as 
0.0057g/cm
2
/yr). Using this precision error, the minimum significant change which can be 
determined with 95% confidence is 0.0388g/cm2 which corresponds to approximately 7% of 
the mean BMD of a 55 yr old Caucasian female. For DEXA of the spine or hip, the precision 
error is approximately half this rate.   
Random error in QUS is due to operator error, normal biological variation as well as machine 
imprecision. To minimize this error, operator training can be optimized specifically with 
respect to positioning of the subject. Room temperature and temperature of the subject’s foot 











precision is dependent on further technological development and the current state of the 
technology precludes the use of QUS for the purpose of monitoring individuals.     
In contrast, when comparing measurements of groups: 
Vtotal = Verror + Vbetween individuals. 
Since the Verror  is random and therefore normally distributed, this quantity should  not bias 
the group mean, thus group means can be compared. However the Vtotal will be larger when 
the measurement instrument is imprecise resulting in broader confidence intervals than 
would be the case for a more precise technique. Statistically significant comparisons for QUS 
therefore rely on a large sample and, as with individuals, the magnitude of the expected 
change. 
2.5 Uses for QUS: Predictive, diagnostic, monitoring. 
Prediction of osteoporostic fracture  
The evidence has been controversial concerning the usefulness of QUS as a screening tool 
for subsequent risk of fracture. However numbers of large prospective and retrospective 
studies have confirmed that the predictive power of calcaneal ultrasound measurement for 
osteoporotic fracture at the hip and lumbar spine is as good as that of BMD measured by 
DEXA at these sites (Camozzi V et al., 2007, Gluer, 2006, Huopio et al., 2004,  López-
Rodríguez F et al., 2003, Langton and Langton, 2000,  Frost et al., 1999, Bauer DC et 
al.,1997, Hans D et al., 1996). Other studies have cautioned that the accuracy of prediction of 
fracture from calcaneal QUS is not very high, and also that QUS should not be used in 
screening for individuals at risk of osteoporosis (Gemalmaz et al., 2007, El-Desouki MI et 











The most recent official position of the ISCD is endorsed by the American association of 
Clinical Endocrinologists, the American society for Bone and mineral research and The 
Endocrine Society. This position states that QUS measured at the heel is able to predict 
fragility fracture in post menopausal women and older men as well as, and independently of 
DEXA. The ISCD also confirms that discordant DXA and QUS results are not necessarily 
due to deficiencies of the device. In particular, the Sahara has been verified in substantive 
prospective studies for fracture prediction (Krieg M-A et al., 2008) 
Diagnosis of osteoporosis according to the WHO definition  
A  number of studies  have shown  QUS measurements  to be only moderately correlated 
with BMD at the hip and lumbar spine as measured by DEXA   (Lappa V et al., 2007, 
Alexandersen P et al., 2005, Babaroutsi et al., 2005,  Frost et. al., 2001, 2000, Gluer et al., 
1999 Gregg et al., 1997). The current consensus is that the WHO criteria cannot be applied to 
devices other  than DEXA (Krieg M-A et al., 2008). Thus T- scores from QUS cannot be 
used according to WHO diagnostic classification for osteoporosis  because they are not 
equivalent to T- scores from DEXA. Indeed, it is the interpretation of QUS results that is the 
most controversial area and therefore the area of greatest opportunity for research.  
The sensitivity and the specificity of QUS in detecting WHO defined to osteoporosis at 
different T-score thresholds are inadequate. 
 
Sensitivity   =              Number of True positives                                                                                                                                                                  
             Number of True positives + Number of False negatives 
 
 A QUS sensitivity of 100% would  recognize all WHO DEXA-defined osteoporotic subjects 












Specificity   =              Number of True negatives                                                                                                                                                                  
             Number of True negatives + Number of False positives  
A specificity of 100% means that all healthy people are recognized as healthy. For 
specificity, a positive result is used to rule in the disease. However any test with very high 
specificity may have very low precision if there are far more true negatives than true 
positives.  
The  specificity and sensitivity of QUS  to detect osteoporosis are dependent on T-score 
threshold values. In an extensive meta-analysis (Nayak  S et al., 2006), it was shown that 
although calcaneal quantitative ultrasound can rule out DXA-determined osteoporosis with 
reasonable certainty in populations with low probabilities of DXA-determined osteoporosis, 
it has a high false positive rate. However it is less useful for screening populations with high 
probabilities of DXA-determined osteoporosis and cannot rule in or rule out DXA-
determined osteoporosis. .  
A possible solution is to establish QUS thresholds for high and low risk of osteoporosis.  For 
individuals with QUS measures in between these two extremes, confirmation with DEXA 
would be required. This strategy was tested using data from the EPIDODS study on  French 
women (aged over 74) in which both QUS and DEXA measurements were taken (Krieg M-A 
et al., 2008). For QUI cutoffs of  59 Units and 83 Units using the Sahara system, and 
validated against DEXA defined osteoporosis, QUS sensitivity  was 89% (11% false 
positives) and specificity was  87% (13% false negatives) (Krieg M-A et al., 2008) 
Monitoring  response to treatment.  
The ability of technology to monitor individual changes in response to interventions requires 
excellent precision and is also determined by the range of response to the intervention. 











randomized controlled trails (RCTs) are needed to determine whether QUS parameters are 
sufficiently sensitive to detect these changes (Hans and Krieg, 2008).  While QUS, especially 
SOS, is precise in the short term, only DXA is recommended by the ISCD for monitoring 
long term to ascertain significant change (Krieg M-A et al., 2008). Insufficient numbers of 
RCTs, studies with low patient numbers and equivocal findings are deficiencies in the current 
state of research in this area. To progress, further quality control and quality assurance 
methods to check device stability also need to be established (Hans et al, 2002). 
2.6. The South African context 
Currently, there is limited and controversial epidemiologic data on BMD and fracture 
incidence in the different ethnic populations in South Africa (Conradie et al., 2005, Hough 
2003, Solomon 1979). Cross sectional data found femoral neck BMD to be higher in black 
than in white South African women, however BMD at the lumbar spine was equivalent 
(Daniels ED et al., 1995). Only one previous study has explored bone health among the 
mixed race community (Micklesfield et al., 2007), and this was limited to children. The 
majority of South Africa’s poorer black and mixed race population attend  health centers for 
primary and secondary level health care where there is no access to DEXA. Also, research 
efforts into public health issues are generally carried out at these community-based health 
care facilities. In such resource-limited settings, it would be highly desirable to use the more 
portable and cheaper ultrasound method for conducting epidemiological studies of bone 
quality rather than rely on referral to a tertiary care facility in an urban center with all the 












3.1  AIM 
The aim of this study was to determine whether Quantitative Ultrasound is sufficiently 
accurate and precise to be used in epidemiological studies of bone strength in black and 
mixed race premenopausal South African women. 
 
 3.2 OBJECTIVES 
1. To describe BUA, SOS and QUI in black and mixed race premenopausal South 
African women.  
2. To determine whether factors associated with QUS measures of bone quality are 
similar to those known to be associated with BMD as measured by DEXA. 
3. To compare QUS associations with those reported in the literature for other 
populations of  premenopausal women.   
4. To monitor the QC output from the two QUS machines used in the study to ensure 
adequate precision throughout the duration of the study. 
5. To validate our results in a separate small sample by  comparing  output from both 















4.1 Overview of the Study  
The data were derived from of a cross sectional study aimed at determining the effects of 
injectable progestogin contraceptive use on bone mass in premenopausal women (Rosenberg 
et al., 2007). The study was conducted between September 2002 and September 2005 at 
community health facilities in two areas – Gugulethu and Mitchells Plain, both situated close 
to Cape Town in the Western Cape Province, South Africa. Black women attended the 
Gugulethu facility and women of mixed race attended Mitchells Plain. These populations 
were selected to meet the aim of the original study. White women not included as very few 
have been exposed to injectable progestin contraceptives. Sampling was on a convenience 
basis and each of the two sites was allocated a Sahara Ultrasound machine (Hologic) for the 
duration of the study in order to measure bone mass. 
A structured questionnaire was administered by trained nurse interviewers in the subject’s 
preferred language (English, Afrikaans or Xhosa), and each subject’s height, weight and 
calcaneal ultrasound measurements were taken. The study protocol was approved by the 
IRBs of Boston University and the University of Cape Town. 
4.2 Study subjects  
Women eligible for the study were aged 18-44, premenopausal, had not been pregnant or had 
not breastfed in the previous year, and did not have an illness or use medication that would 
influence their bone health. Medical conditions for exclusion from the study were illnesses 
requiring bed-rest for more than 6 weeks in the past 12 months, thyroid, parathyroid and 
pituitary disease, cancer, sarcoidosis, rheumatoid arthritis, chronic liver and kidney disease, 











corticosteroids, drugs for hypo, hyper-thyroidism or parathyroidism, thiazide diuretics or 
calcium supplements for more than six months in the last five years were also excluded. 
Written informed consent was obtained from all subjects.  
Of the 4362 women approached, 3957 were willing to participate, of whom 413 were 
excluded for failing to meet study criteria or because the Sahara measurement failed, leaving 
3544 women. We excluded 51 from the analysis because of ultrasound measures below or 
above the 0.5 percentile of measures. This equated to broadband ultrasonic attenuation 
(BUA) <= 45 and >=117 or speed of sound (SOS) <=1500 and >=1645.5, leaving 3493 
women, of whom 1598 were black and 1895 were of mixed race. 
4.3 Interview 
The study nurses administered standard questionnaires  to collect  information on 
demographic factors, reproductive and contraceptive history, and lifestyle factors.  
Information was obtained on age, ethnicity, highest standard passed at school, training after 
school and employment status. Details were elicited for marital status, age at menarche, age 
at each pregnancy and contraceptive use before and in intervals between pregnancies. These 
latter details were required specifically for the original study on use of injectable 
contraceptives and bo e health. 
Alcohol  and smoking 
Information was obtained for never, past or current use, as well as duration of alcohol intake 
in years and quantity of week and weekend drinking. For current and past cigarette smokers, 
women were asked about the number of cigarettes smoked per day and years of smoking as 













Current calcium intake 
Questions were based on a previous study that evaluated intake of calcium rich food in a 
similar population in terms of daily intake of dairy servings (1 dairy serving =  1 glass of 
milk) and which had been validated against three day records (Micklesfield, unpublished 
data). Women were asked about the quantity and frequency of milk drinks, milk in coffee tea 
and cereal, as well as frequency of eating cheese, pizza, macaroni and cheese and sardines.  
 Physical activity  
The physical activity section of the questionnaire was adapted to the South African context 
(Micklesfield  et al., 2003, Kriske et al., 1988).  A previous study on  black and mixed race 
women aged 22 to 59 (Micklesfield et al., 2003)  showed that  adjusted BMD of the femoral 
neck,  as measured by DEXA, was most strongly associated with physical activity that was 
undertaken during adolescence (14 – 21 years).  In Micklesfield’s study, activities were 
categorized into household, occupational, leisure time and transport, and results showed that 
walking for transport and walking with loads, as well as sporting activities were the best 
predictors of total proximal femur BMD. These results informed   the design of our own 
questionnaire as to which physical activities to focus on, and how to measure them. 
For our study historical information on physical activity was obtained for three epochs – 
primary school, high school and post-school. Information was obtained on walking for 
transport, for daily tasks (e.g. carrying water) and at work, as well as on leisure-time activity 











For each of these activities, if the duration was above 30 minutes, we recorded information 
on the number of hours and minutes, number of days per week, number of months per year 
and numbers of years 
To calculate the total amount of hours for each activity in each epoch the following algorithm 
was used. 
Total Hours = (Total minutes /day) /60 * (Total days/week) * 4.3 * (Total months /year) * (Total years) 
To take account of load bearing during activities, the impact of loading from each physical 
activity was ranked on a 0 to 3 scale with “0” indicating non-weight-bearing and “3” 
indicating high impact.  (Groothausen et al., 1997). Impact factors for walking activities 
involving herding cattle, walking to public transport, for pleasure, to the shops scored 1. 
Walking to fetch water and walking to collect wood –  in both cases carrying load halfway 
scored 1.5.  Walking carrying a child (both ways) scored 2. 
Leisure and sporting activity impact scores are shown below in Table 1. 
Table 1: Impact factors allocated to sports and leisure activities 
Activity Impact factor 
Swimming, Cycling 0 
Walking 1 
Jogging, Tennis, Dancing Athletics, Hockey, Softball/soccer 2 
Volley-ball, netball, Aerobic dancing 3 
 
Total impact hours (TIH) were calculated for each activity in each of the three epochs by 
multiplying total hours by the impact factor. Thus activities with and impact factor of 0 did 
not count toward the TIH.   As the range of TIH for was very large, we limited our analysis 













Weight and height measurements were taken using a SECA (Hamburg, Germany) scale and 
SECA height measure with participants wearing only light clothing and no shoes.  Body 




. Bone mass 
was assessed using a gel-coupled (dry) quantitative ultrasound system, the Sahara (Hologic: 
SN 03281,   SN 03278).  
4.5 Quality Control  
Operator Proficiency 
The study nurses were trained in using the QUS machines until they achieved proficiency 
such that the coefficient of variation (CV) for  repeated measures of the same subject was 
within the machine specification as laid down by Hologic. 
Instrument Quality Control 
During the study proper, on a daily basis a phantom was used to check the quality control 
(QC) of each machine. The machine output for this procedure is in terms of QAB and QAS.     
These are dimensionless quantities calculated by dividing the phantom  BUA and SOS 
measured in the calibration procedure by the values that were specified for that phantom by 
the manufacturer. Thus QAB =  Phantom BUA (QC measurement) / Phantom BUA 
(manufacturer specification). Likewise QAS  =  Phantom SOS (QC ) / Phantom SOS 
(specification).  QAB and QUS readings were required to fall within the limits of 0.86–1.14 
and 0.986–1.014 respectively, with optimum readings of 1.00 for both. If the machine did not 
pass the QC, it was recalibrated. If it continued to fail QC, the transducers pads were 
replaced. The results for this daily QC check were evaluated throughout the study and are 











values for a machine drifted outside Sahara specification for QAB and QAS, but still passed 
its QC test, the machine was recalibrated.  
4.6 Comparison of QUS machines 
To compare the output from the two QUS machines, measurements on a number of subjects 
were done on each of the two machines by 1 operator at the same visit, the   measurement on 
the second machine being done immediately after the first. These trials were done on three 
separate occasions over the duration of the study - on October 2003 (N=50), October 2004  
(N=48) and October 2005 ( N=48).  The results were pooled to allow for comparison of mean 
BUA and  mean SOS  between the two machines over a   range of response similar to that 
which we  expected in the study proper. 
4.7 Agreement between QUS and DEXA : Small Study 
To assess correlation of the QUS measures with DEXA measures, a sample of 14 young 
women who had been recruited for another study  were measured on both QUS machines and 
had  a DEXA scan (DXA Hologic, Model: Discovery W   S/N 80196) . These measurements 
were taken at the MRC/UCT Research Unit for Exercise Science and Sports Medicine at the 
same visit. Different operators performed the DEXA and the QUS measurements 
respectively. For DEXA, BMD results for femoral neck, femoral trochanter, total hip (the 
combination of femoral neck, femoral trochanter and intertrochanteric areas), and total 
lumbar spine (L1-4) are reported here. These are compared to BUA, SOS and estimated 














4.8 Statistical Analysis  
Categories for  Risk factors  
True categorical data (ethnicity, nulli-parity and never, past or current smoking or alcohol 
use) were left in their natural categories for analysis.  The distributions of the continuous risk 
factor variables were examined for the study sample as a whole, and categories were formed 
for each factor. Decisions for category boundaries were made based on both the  
distributional characteristics of the variable as well as its biological nature. Physical activity 
in the different epochs and calcium intake were analyzed by quartile.  
Distributions of the risk factors were calculated separately for black and mixed race women. 
Medians were compared for the two study groups using Kruskall-Wallis tests, and 
distributions across categories were compared using Chi-squared tests.  
MultivariableAnalysis 
To systematically explore the effects of risk factors on BUA, SOS and QUI, we first   
calculated the crude means and standard deviations for these QUS measures for all  
categories of all risk factors  for which we had  data. Using these results, and our a priori  
knowledge from the literature of  expected  associations of QUS measures with age and with  
BMI, we calculated  age-adjusted means  and adjusted means for age +  each  risk factor for 
three strata of BMI for black and mixed race women separately. This was done for BUA, 
SOS and QUI. These results helped to inform our final multivariable model in which we 
decided to include age, height, BMI, education, age at menarche, nulli-parity, smoking and 
alcohol use, calcium intake and early physical activity. Adding contraceptive use did not 
affect the results. We obtained adjusted means of BUA, SOS and QUI using linear regression 











the exposure category of interest into a term in the regression model. To further investigate 
residual confounding by BMI of height, physical activity and age at menarche, the 
multivariable regression model was again tested according to three strata of BMI. Smoking 
was further analyzed among mixed race women but this was not possible in black women 
due to low numbers of smokers. Adjusted means were calculated for ever versus never 
smokers, for numbers of cigarettes smoked per day and for smoking years * numbers of 
cigarettes smoked per day.  
Quality Control 
Means, standard deviations and coefficients of variation were calculated for the operator and 
instrument quality control trials performed prior to commencement of the study proper. 
For instrument QC over the duration of the study, monthly means for QAB and QAS were 
calculated and plotted on graphs to allow for the detection of any seasonal trend or consistent 
deviation beyond the recommended QC limits.   
Comparison of QUS machines 
 T-tests of mean differences for BUA and SOS between the two machines were used to 
determine whether these differences were significant. In addition, BMD values from the two 
QUS machines generated in the separate small study (N=14) were compared using the Bland-
Altman method to test for agreement.     
Comparison of QUS and DEXA 
Comparisons of QUS output and DEXA measurements were made using  Pearson correlation 
coefficients as  well as Bland-Altman analyses for determining agreement between different 
measurement methods. All analyses were performed using STATA software version 9.0 














5.1. Description of subjects 
 
The demographic, socioeconomic and reproductive characteristics of the study sample by 
ethnicity are shown in Table2. Black women were slightly younger, were taller and had 





for mixed race women these were 28 yrs, 154 cm and 25 kg/m
2
.  Black women had 
completed more years of education than women of mixed race - median education levels 
were Grade 11 and Grade 9 respectively. In addition, black women experienced menarche 
later than mixed race women (Median age at menarche = 15 years and 13 years), and had 
fewer live births (Median number of live births = 1 for black women and 2 for mixed race 
women). Using Kruskall-Wallis tests, age differences were significant at p<0.05 while all 
other differences reached significance levels of p< 0.001.  
For lifestyle characteristics (Table 3), black women drank less alcohol and smoked less. 90 % 
of black women had never smoked whereas 67% of mixed race women were smokers,  either 
current or past. Among those who had ever smoked, the median number of cigarettes smoked 
per day and the median number of years smoking were 3 cigarettes per day and 2 years for 
black women; and 6 cigarettes per day and 4 years for mixed race women. Black women had 
a lower calcium intake than mixed race women (median daily servings = 8 and 13 
respectively). For all of the physical activity epochs, total impact hours for physical activity 
were better analyzed in quartiles as the distributions were notably wide and skew.  
Comparing distributions across quartiles, black women engaged in more physical activity in 











lifestyle differences were significant at p<0.001, using  Kruskall-Wallis and  Chi-squared 
tests. 
Table 2:  Demographic, socioeconomic and reproductive characteristics
 
of study participants  
 
Characteristic Black Subjects 
N=1598 
N  (%) 
Mixed race Subjects 
N=1895 
N  (%) 
Age (years) *   
18 – 19 141 (8.8) 177 (9.3) 
20 – 24 422 (26.4) 512 (27.0) 
25 – 29 373 (23.3) 363 (19.2) 
30 – 34 299 (18.7) 311 (16.4) 
35 – 39 227 (14.2) 284 (15.0) 
40 – 44 136 (8.5) 248 (13.1) 
Mean (Med) SD 28.4 (27) 7.68 29.1 (28) 7.68 
   
BMI (kg/m
2
)**   
< 23 235 (14.7) 638 (33.7) 
23  - 24 221 (13.8) 263 (13.9) 
25  - 29    533 (33.4) 507 (26.7) 
30  - 34 386 (24.2) 306 (16.2) 
   35+ 223 (13.9) 181 (9.5) 
Mean (Med) SD 28.4 (27) 5.73 26.0 (25) 6.01 
   
Height (cm) **   
< 153 211 (13.2) 762 (40.2) 
153 – 157 386 (24.2) 491 (25.9) 
158  – 161 466 (29.1) 408 (21.5) 
   162+  535 (33.5) 234 (12.4) 
Mean (Med) SD 159.0 (159) 5.62 154.7 ( 154) 6.41 
   
Education**   
Grade 9 or less  453 (28.4) 1000 (52.8) 
Grade 10 – 11 681 (42.6) 580 (30.6) 
Grade  12 464 (29.0) 315 (16.6) 
Median (Range) 11 (0 ; 12) 9 (0 ; 12) 
   
Age at Menarche**   
< 13 120 (7.5) 591 (31.2) 
13 – 14  576 (36.1) 771 (40.7) 
15 340 (21.3) 231 (12.2) 
16+  427 (26.7) 301 (15.9) 
Missing  135 (8.5) 1 (0.1) 
Mean (Med) SD 14.7 (15) 1.75 13.5 (13) 1.90 
   
Parity**   
None 534 (33.4) 286 (15.1) 
1+ 1064(66.6) 1609 (84.9) 
Med live births  (Range) 1 (0 ; 6) 2 (0 ; 7) 














Table 3: Lifestyle characteristics of study participants 
 
Characteristic Black Subjects  
N=1598 
N  (%) 
 Mixed race Subjects 
N=1895 
N  (%) 
Smoking Status**   
Ever smoked** 159 (9.9) 1283 (67.7) 
Never  smoked 1439 (90.1) 612 (32.3) 
   
Non-smoker** 1439 (90.1) 612 (32.3) 
Ex-smoker 59 (3.7) 138 (7.3) 
Current smoker 100 (6.3) 1145 (60.4) 
   
Median (Range) cigarettes smoked  (Ever smokers only)** 3 (1 ; 20) 6 (1 ; 60) 
Median (Range)  years of smoking  (Ever smokers only)** 2 (1 ; 5) 4 (1 ; 5) 
   
Alcohol Use**   
Non-drinker 1167 (73.0) 998 (52.7) 
Ex-drinker 112 (7.0) 210 (11.1) 
Current drinker 319 (20.0) 687 (36.3) 
   
Quartile of Calcium Intake**   
1  (0 – 5.25) 540 (33.8) 359 (18.9) 
2  (5.3 – 10.75) 482 (30.1) 401 (21.2) 
3  (10.8 – 15.25) 287 (18.0) 615 (32.5) 
4  (15.3 – 50.25) 289 (18.1) 520 (27.4) 
Mean (Med) SD 9.5 (8) 7.34 12.3 (13) 6.80 
   
Quartile of Primary School Physical Activity (TIH†)**   
1  (0 - 310) 236 (14.8) 638 (33.7) 
2  (311 – 1118) 272 (17.0) 600 (31.7) 
3  (1119 – 2582) 389 (24.3) 485 (25.6) 
4  (2583 – 31579) 700 (43.8) 172 (9.1) 
Missing 1 (0.1)  
Mean (Med) SD 3364 (2124) 3648 1060 (722) 1284 
   
Quartile of  High School Physical Activity (TIH†)**   
1  (0) 631 (39.5) 811 (42.8) 
2  (1 - 258) 61 (3.8)  254 (13.4) 
3  (259  - 986) 353 (22.1) 510 (26.9) 
4  ( 987 - 11834) 553 (34.6) 320 (16.9) 
Mean (Med) SD 929 (473) 1346 491 9172) 821 
   
Quartile of  After School Physical Activity (TIH†)**   
1  (0) 786 (49.2) 664 (35.0) 
2  (1 - 413) 63 (3.9) 247 (13.0) 
3  (414 - 4128) 262 (16.4) 604 (31.9) 
4  (4129 - 52942) 486 (30.4) 380 (20.1) 
Missing 1 (0.1)  
Mean (Med) SD 8408 (5582) 8680 4102 (2413) 5131 













5.2 Exploratory analysis (Tables 4 and 5) 
 
In black women there were appreciable differences in  BUA, SOS and QUI across the BMI 
strata, and  adding age to the model consistently altered the mean QUS values. In general, 
within BMI strata the mean age-adjusted QUS parameters were altered only by a small 
amount when adding additional variables to the age-adjusted mean. For BUA, adding  age at 
menarche altered the age-adjusted mean in all BMI strata. Height and total physical activity 
also had a small effect. Age-adjusted  mean SOS was somewhat influenced by age at 
menarche and to a lesser extent by height, number of live births, education, injectable and 
oral contraceptive use. Factors affecting QUI were similar to those for BUA and SOS 
combined. Other variables did not alter the age-adjusted mean. 
For mixed race women there were also appreciable differences across the BMI strata, and   
again age was associated with  BUA, SOS and QUI.  For BUA, adding age at  menarche, 
height, number of live births, Oral Contraceptive (OC) use, calcium intake and total physical 
activity resulted in small changes. This was the same for SOS and QUI except that physical 
activity in primary school rather than total physical activity predominated, and live births 
predominated over age at menarche. Opposite effects were present for height in the lowest 
and highest BMI strata.   
Following this exploratory analysis, and guided by what is published in the literature on 
factors associated with DEXA BMD, it was decided to include the following variables in our 
multivariable model: Age, BMI, height, education, age at menarche, number of live births, 












The effects of injectable contraceptive (IC) use on bone mass are reported elsewhere 
(Rosenberg et al., 2006). 








Mean BUA 76.9 80.7 85.0 
Mean BUA adj for age 77.2 80.8 84.7 
Mean BUA adj for age & height 77.1 80.8 84.7 
Mean BUA adj for age & age at menarche (excl missing) 77.0 80.9 84.5 
Mean BUA adj for age & live births 77.2 80.8 84.7 
Mean BUA adj for age & education 77.2 80.8 84.7 
Mean BUA adj for age & ICuse (never,past. current) 77.2 80.8 84.7 
Mean BUA adj for age & OCuse (never,past. current) 77.2 80.8 84.7 
Mean BUA adj for age &  smoking  (never,past. current) 77.2 80.8 84.7 
Mean BUA adj for age &  alcohol (never,past. current) 77.2 80.8 84.7 
Mean BUA adj for age & Ca intake 77.2 80.8 84.7 
Mean BUA adj for age & Total exercise 77.2 80.9 84.7 
Mean BUA adj for age &  Primary school exercise 77.2 80.8 84.7 
 
 BMI<25 BMI 25-29.9 BMI 30+ 
Mean SOS 1561.1 1563.0 1565.3 
Mean SOS adj for age 1561.3 1563.1 1565.1 
Mean SOS adj for age & height 1561.7 1563.0 1564.9 
Mean SOS adj for age & age at menarche(excl missing) 1560.9 1563.0 1564.9 
Mean SOS adj for age & live births 1561.2 1563.1 1565.2 
Mean SOS adj for age & education 1561.0 1563.1 1565.3 
Mean SOS adj for age & ICuse (never,past. current) 1561.0. 1563.2 1565.2 
Mean SOS adj for age & OCuse (never,past. current) 1561.4 1563.0 1565.1 
Mean SOS adj for age &  smoking  (never,past. current) 1561.3 1563.1 1565.1 
Mean SOS adj for age &  alcohol (never,past. current) 1561.3 1563.1 1565.1 
Mean SOS adj for age & Ca intake 1561.3 1563.1 1565.1 
Mean SOS adj for age & Total exercise 1561.3 1563.1 1565.1 
Mean SOS adj for age &  Primary school exercise 1561.3 1563.1 1565.1 
 
 BMI<25 BMI 25-29.9 BMI 30+ 
Mean QUI 100.6 102.9 105.7 
Mean QUI adj for age 100.8 103.0 105.4 
Mean QUI adj for age & height 100.9 103.0 105.3 
Mean QUI adj for age & age at menarche (excl missing) 100.6 103.0 105.3 
Mean QUI adj for age & live births 100.8 103.0 105.4 
Mean QUI adj for age & education 100.8 103.0 105.4 
Mean QUI adj for age & ICuse (never,past. current) 100.7 103.1 105.5 
Mean QUI adj for age & OCuse (never,past. current) 100.8 103.0 105.4 
Mean QUI  adj for age &  smoking  (never,past. current) 100.8 103.0 105.4 
Mean QUI adj for age &  alcohol (never,past. current) 100.8 103.0 105.4 
Mean QUI adj for age & Ca intake 100.8 103.0 105.4 
Mean QUI adj for age & Total exercise 100.8 103.1 105.4 












Table 5  Exploratory analysis for QUS measures in mixed race women (N=1895) 
 
 BMI<25 BMI 25-29.9 BMI 30+ 
Mean BUA 75.5 78.5 80.5 
Mean BUA adj for age 75.7 78.4 80.2 
Mean BUA adj for age & height 75.7 78.4 80.1 
Mean BUA adj for age & age at menarche 75.8 78.4 80.1 
Mean BUA adj for age & live births 75.6 78.5 80.3 
Mean BUA adj for age & education 75.7 78.4 80.2 
Mean BUA adj for age & ICuse (never,past. current) 75.7 78.4 80.2 
Mean BUA adj for age & OCuse (never,past. current) 75.7 78.3 80.1 
Mean BUA adj for age &  smoking  (never,past. current) 75.7 78.4 80.2 
Mean BUA adj for age &  alcohol (never,past. current) 75.7 78.4 80.2 
Mean BUA adj for age & Ca intake 75.7 78.4 80.1 
Mean BUA adj for age & Total exercise 75.7 78.4 80.1 
Mean BUA adj for age &  Primary school exercise 75.7 78.4 80.2 
 
 BMI<25 BMI 25-29.9 BMI 30+ 
Mean SOS 1561.6 1559.2 1560.5 
Mean SOS adj for age 1561.3 1559.8 1560.8 
Mean SOS adj for age & height 1561.6 1559.8 1560.2 
Mean SOS adj for age & age at menarche 1561.3 1559.7 1560.7 
Mean SOS adj for age & live births 1560.9 1560.0 1561.2 
Mean SOS adj for age & education 1561.2 1559.8 1560.8 
Mean SOS adj for age & ICuse (never,past. current) 1561.3. 1559.7 1560.9 
Mean SOS adj for age & OCuse (never,past. current) 1561.3. 1559.7 1560.7 
Mean SA adj for age &  smoking  (never,past. current) 1561.4 1559.8 1560.7 
Mean SOS adj for age &  alcohol (never,past. current) 1561.3 1559.8 1560.8 
Mean SOS adj for age & Ca intake 1561.3 1559.9 1560.8 
Mean SOS adj for age & Total exercise 1561.3 1559.8 1560.8 
Mean SOS adj for age &  Primary school exercise 1561.2 1559.8 1561.0 
 
 BMI<25 BMI 25-29.9 BMI 30+ 
Mean QUI 100.2 100.6 101.8 
Mean QUI adj for age 100.2 100.7 101.8 
Mean QUI adj for age & height 100.3 100.7 101.5 
Mean QUI adj for age & age at menarche 100.2 100.6 101.7 
Mean QUI adj for age & live births 100.0 100.8 102.0 
Mean QUI adj for age & education 100.1 100.7 101.8 
Mean QUI adj for age & ICuse (never,past. current) 100.1 100.6 101.8 
Mean QUI adj for age & OCuse (never,past. current) 100.2 100.6 101.7 
Mean QUI  adj for age &  smoking(never,past. current) 100.2 100.7 101.7 
Mean QUI adj for age &  alcohol (never,past. current) 100.2 100.7 101.8 
Mean QUI adj for age & Ca intake 100.2 100.7 101.8 
Mean QUI adj for age & Total exercise 100.2 100.7 101.8 












5.3 Final multivariable analysis.   
In black subjects (Table 6), the fully adjusted means for all QUS measures – BUA, SOS and 
QUI increased significantly with increasing age and with increasing BMI. All three measures 
decreased significantly with increasing age at menarche. SOS and QUI decreased with 
increase in height and were also lower among parous women when compared with 
nulliparous women. BUA was not affected by these variables. There were small but 
nonsignificant positive associations of BUA, SOS and QUI with physical activity in primary 
school. There was no association between the three QUS measures and education level, 
alcohol use, cigarette smoking and current calcium intake.  
In women of mixed race (Table 7), fully adjusted mean BUA and QUI increased significantly 
with increasing age but for SOS, there was an increase which was nonsignificant.  BUA 
increased significantly with increasing BMI but SOS decreased slightly. As a result, QUI 
also increased with BMI but to a lesser extent. SOS and QUI decreased as height increased, 
with a similar but weaker trend for BUA. All three QUS measures were significantly lower in 
parous compared to nulliparous women. All measures also decreased with increasing age at 
menarche, but none of the trends was significant.  In addition BUA, SOS and QUI were all 
significantly and positively associated with primary school physical activity. There was a 
weak association of decreased SOS with smoking. No associations were found with 
education level, alcohol intake or calcium intake.  
Further stratified analysis of associations between QUS measures and height, QUS and age at 
menarche, and QUS and physical activity, according to three levels of BMI  (<25 kg/m
2
 , 25 
– 29 kg/m
2
, 30+  kg/m
2
) did not reveal any differences as compared with the original non-











Table 6. Associations of   risk factors with BUA, SOS and QUI  among Black women  
 


















Age (years)   0.05   0.039   0.027 
18 – 19 77.1 (12.3) 78.8  1564 (25.1) 1561  102.0 (14.2) 101.5  
20 – 24 80.5 (13.3) 81.4  1563 (24.8) 1563  103.1 (14.3) 103.1  
25 – 29 81.4 (12.6) 81.2  1561 (25.2) 1562  102.5 (14.2) 102.7  
30 – 34 80.6 (13.4) 80.1  1561 (27.2) 1562  102.1 (15.6) 102.3  
35 – 39 83.4 (14.1) 82.6  1566 (25.4) 1567  105.3 (15.1) 105.2  
40 – 44 85.2 (14.3) 83.8  1568 (28.1) 1568  106.9 (16.4) 106.3  
          
BMI (kg/m
2
)   <0.001   0.044   <0.001 
< 23 76.2 (12.6) 76.4  1562 (25.3) 1562  100.5 (14.6) 100.6  
23 -  24 77.6 (13.0) 77.9  1561 (25.6) 1561  100.7 (14.7) 100.9  
25 -  29 80.7 (12.9) 80.8  1563 (25.7) 1563  102.9 (14.6) 103.1  
30 -  34 84.7 (13.2) 84.5  1565 (25.0) 1565  105.3 (14.5) 105.3  
35+ 85.5 (13.1) 85.1  1566 (28.1) 1565  106.2 (15.6) 105.6  
          
Height (cm)    0.204   <0.001   0.037 
< 153 79.7 (13.9) 79.5  1566 (26.5) 1566  103.9 (15.1) 103.8  
153 – 157 82.3 (14.0) 81.9  1567 (26.9) 1567  105.2 (15.7) 105.0  
158  – 161 81.1 (12.8) 81.0  1562 (24.9) 1563  102.8 (14.3) 102.8  
162+  81.2 (13.1) 81.6  1561 (25.2) 1561  102.1 (14.6) 102.4  
          
Education   0.497   0.831   0.962 
Grade 9 or less  81.5 (13.9) 80.8  1565 (26.6) 1564  103.9 (15.4) 103.2  
Grade 10 – 11 81.1 (13.3) 81.3  1563 (25.6) 1563  103.1 (14.8) 103.3  
Grade  12 81.2 (13.0) 81.5  1563 (25.4) 1563  103.0 (14.5) 103.3  
          
Age at Menarche   0.060   0.009   0.010 
< 13 82.8 (13.9) 83.4  1567 (23.5) 1566  105.4 (14.3) 105.5  
13 – 14  81.2 (12.9) 81.3  1564 (25.7) 1564  103.5 (14.7) 103.6  
15 80.9 (13.3) 80.8  1564 (26.7) 1564  103.3 (15.0) 103.3  
16+  80.8 (13.5) 80.6  1560 (25.5) 1560  101.9 (14.9) 101.7  
          











Live Births   0.926   0.003   0.000 
None 79.8 (13.0) 81.2  1565 (24.5) 1567  103.5 (14.2) 104.8  
1+ 82.0 (13.5) 81.3  1562 (26.4) 1562  103.2 (15.2) 102.5  
          
Primary School PA (TIH‡)   0.183   0.842   0.534 
1  (0 - 310) 79.8 (13.5) 79.8  1562  (25.9) 1562  102.1 (14.8) 102.0  
2 (311 – 1118) 81.4 (13.1) 81.6  1565 (26.7) 1565  104.1 (15.0) 104.3  
3  (1119 – 2582) 80.9 (12.9) 81.0  1563 (25.1) 1563  103.0 (14.5)) 103.0  
4  (2583 – 31579) 81.9 (13.7) 81.8  1563 (25.9) 1563  103.5 (15.0) 103.5  
          
Smoking Status   0.818
†
   0.865
†
   0.847
†
 
Non-smoker 81.3 (13.2) 81.2  1563 (25.7) 1563  103.2 (14.8) 103.2  
Ex-smoker 80.8 (15.7) 81.6  1566 (27.0) 1565  104.0 (15.6) 103.9  
Current smoker 81.3 (14.7) 82.1  1565 (26.6) 1564  103.8 (15.9) 104.0  
          
Alcohol Use   0.323
†
   0.304
†
   0.419
†
 
Non-drinker 81.5 (13.2) 81.6  1563 (26.0) 1564  103.4 (14.8) 103.5  
Ex-drinker 80.3 (14..5) 80.3  1566 (25.4) 1566  104.1 (15.3) 104.0  
Current drinker 80.5 (13.7) 80.3  1563 (25.4) 1562  102.8 (15.0) 102.3  
          
Quartile of Calcium Intake   0.851   0.686   0.695 
1  (0 – 5.25) 81.3 (13.9) 81.2  1563 (25.9) 1563  103.1 (15.1) 103.1  
2  (5.3 – 10.75) 81.0 (12.8) 81.2  1563 (26.1) 1563  103.1 (14.7) 103.1  
3  (10.8 – 15.25) 81.2 (13.7) 81.1  1565 (26.0) 1565  104.1 (15.0) 104.0  
4  (15.3 – 50.25) 81.6 (13.2) 81.4  1563 (25.1) 1563  103.1 (14.6) 103.2  
 
 
* Control for age,  BMI, height, education, age at menarche, number of live births, alcohol use, cigarette smoking, physical activity level at primary school  and 
calcium intake. 
 











Table 7. Associations of risk factors with BUA, SOS and QUI  among  Mixed race women 
 
















P for trend 
Age (years)   0.001   0.131   0.024 
18 – 19 75.6  (13.6) 74.8  1565 (26.9) 1559  101.4  (15.5) 98.8  
20 – 24 75.9 (13.1) 75.7  1560 (28.0) 1558  99.9 (16.0) 99.0  
25 – 29 77.9 (13..3) 77.8  1561 (26.1) 1561  100.9 (15.1) 100.8  
30 – 34 78.1 (13.7) 78.1  1560 (27.1) 1562  100.8 (15.7) 101.5  
35 – 39 79.7 (14.8) 80.2  1562 (28.9) 1564  102.0 (17.1) 103.2  
40 – 44 78.6 (15.1) 79.2  1558 (28.4) 1561  99.9 (16.9) 101.5  
          
BMI (kg/m2)   <0.001   0.467   0.164 
< 23 75.4 (13.7) 75.6  1563 (28.3) 1563  100.6 (16.3) 100.7  
23 – 24 75.8 (13.2) 75.8  1559 (29.6) 1559  99.2 (16.6) 99.1  
25 -  29 78.4 (13.9) 78.4  1559 (26.4) 1560  100.5 (15.6) 100.6  
30 -  34 80.2 (13.7) 79.8  1560 (26.8) 1560  101.5 (15.6) 101.2  
35+ 80.9 (14.1) 80.8  1561 (26.7) 1561  102.3 (15.7) 102.3  
          
Height (cm)    0.260   <0.001   <0.001 
< 153 78.4 (14.2) 78.1  1565 (27.7) 1565  102.6 (16.1) 102.6  
153 – 157 77.3 (13.6) 77.3  1560 (28.1) 1560  100.2 (16.2) 100.3  
157.1 – 161.9 76.7 (13.3) 76.9  1556 (25.3) 1556  98.6  (14.8) 98.6  
162+  76.8 (14.2) 77.4  1558 (28.6) 1557  99.1 (16.8) 99.1  
          
Education   0.058   0.517   0.262 
Grade 9 or less  77.2 (14.1) 77.0  1560 (28.1) 1560  100.1 (16.4) 100.3  
Grade 10 – 11 77.7 (13.2) 77.9  1562 (26.2) 1561  101.1 (15.1) 101.1  
Grade  12 78.4 (14.2) 78.6  1563 (28.3) 1561  101.8 (16.5) 101.4  
 
 
         
Age at Menarche   0.116   0.378   0.239 
 < 13 78.3 (13.6) 78.3  1562 (27.0) 1562  101.4 (15.6) 101.4  
13 – 14  77.3 (14.4) 77.4  1560 (28.5) 1560  100.4 (16.6) 100.4  
15 76.9 (13.7) 76.9  1561 (26.9) 1561  100.5 (15.7) 100.5  
16+  77.0 (13.2) 77.0  1560 (27.1) 1560  100.1 (15.5) 100.2  
          











Live Births   0.003   0.000   0.000 
None 78.0 (13.9) 80.1  1568 (27.3) 1568  103.8 (15.9) 104.7  
1+ 77.5 (13.9) 77.1  1560 (27.5) 1559  100.1 (16.0) 100.0  
          
Primary School PA (TIH‡)   0.066   0.003   0.006 
1  (0 - 310) 76.9 (13.9) 76.9  1560 (27.4) 1559  99.1 (15.9) 99.7  
2 (311 – 1118) 77.4 (14.2) 77.2  1560 (28.2) 1560  100.4 (16.5) 100.2  
3  (1119 – 2582) 78.1 (13.4) 78.3  1562 (27.5) 1563  101.4 (15.8) 101.8  
4   (2583 – 31579) 79.1 (13.9) 78.8  1564 (26.3) 1565  102.7 (15.3) 103.0  
          
Smoking Status   0.393
†
   0.090
†
   0.147
†
 
Non-smoker 78.3 (13.8) 77.7  1562 (27.9) 1562  101.6 (16.1) 101.3  
Ex-smoker 76.6 (13.6) 75.9  1556 (27.1) 1556  98..4  (15.7) 98.2  
Current smoker 77.3 (13.9) 77.7  1560 (27.5) 1560  100.5 (16.0) 100.6  
          
Alcohol Drinking Status   0.948
†
   0.850
†
   0.878
†
 
 Non-drinker 77.6 (13.7) 77.5  1561 (27.2) 1561  100.8 (15.9) 100.7  
 Past drinker 78.0 (14.6) 77.8  1560 (28.8) 1562  100.7 (16.8) 101.2  
 Current drinker 77.3 (13.9) 77.5  1561 (27.7) 1560  100.6 (16.0) 100.5  
          
Quartile of Calcium Intake   0.156   0.401   0.276 
1  (0 – 5.25) 76.8 (13.2) 77.0  1560 (27.3) 1560  99.9 (15.6) 100.1  
2  (5.3 – 10.75) 77.2 (13.9) 77.2  1561 (27.7) 1561  100.8 (16.1) 100.7  
3  (10.8 – 15.25) 77.5 (13.9) 77.5  1560 (27.7) 1560  100.3 (16.0) 100.4  
4  (15.3 – 50.25) 78.4 (14.3) 78.2  1562 (27.7) 1562  101.6 (16.2) 101.4  
 
 
Control for age,  BMI, height, education, age at menarche, number of live births, alcohol use, cigarette smoking, physical activity level at primary school  
and calcium intake. 
 













Smoking in mixed race women  (Table 8) 
There was a marginal  decrease in the adjusted mean BUA for ever versus never smokers, 
but  no association was evident for numbers of cigarettes smoked, or  for (numbers of 
cigarettes smoked  x years of smoking). For the latter factor, BUA actually increased in the 
highest category of smoking to above non-smoker levels.  
Mean  SOS was also lower in ever-smokers than  in never-smokers, although again there 
was no trend  for either  number of cigarettes or for (number of cigarettes/day  x years of 
smoking).  For QUI, results followed the same pattern as for SOS for the never- versus 
ever-smokers, but the effect was of smaller magnitude. 
 
Table 8. Adjusted means for QUS measurements according to smoking in mixed race women. 
 






Smoking status     
     
Never smoked cigarettes 612 77.7 1562 101.3 
Ever smoked cigarettes 1283 77.5 1560 100.4 
     
Numbers of cigarettes     
Never smoked cigarettes 612 77.7 1562 101.3 
Smoke/d 1-5 cigs/day 363 77.1 1559 99.8 
Smoke/d  5 – 20 cigs/day 769 77.6 1561 100.7 
Smoke/d  > 20 cigs/day  151 77.7 1559 100.0 
     
Number of cigarettes/day  x 
Years of smoking 
 
   
Never smoked cigarettes 612 77.7 1562 101.3 
Smoke/d  1 - 40 cig years 898 77.0 1560 100.2 
Smoke/d   > 40 cig years 385 78.5 1560 100.8 
     
 
*Control for age,  BMI, height, education, age at menarche, number of live births, alcohol use,  physical 


















5.4 Quality Control 
 
Short term machine and operator precision   
 
Operator training sessions took place prior to commencement of the study proper. Table 9 
shows the coefficients of variation (CVs) for BUA, SOS and QUI for each operator using 
one machine and measuring one subject N times. The high CVs for all operators for the 
Mitchells Plain (MP) machine for the trials on 28 May 2002, as compared with their results 
for the Gugulethu (GU) machine, suggested that there was a problem with the machine and 
it was sent back to the manufacturer for assessment. The machine was subsequently 
returned to us with new transducer pads and the manufacturer’s guarantee of  full working 
order.  Both operators assigned to this machine had two subsequent training sessions, while 
interviewer 3 on the GU machine had a single further session in order to achieve CVs 
within the Hologic specifications.  
Table 9: Coefficients of variation for BUA , SOS and QUI for  training trials of operators. 
 
 BUA 
CV ( %) 
SOS 
CV ( %) 
QUI 
CV ( %) 
Hologic  specification 3.7 0.3 2.6 
Date   Interviewer Machine N    
28/05/02 1 GU 10 3.4 0.1 1.6 
28/05/02 1 MP 10 5.0 0.6 3.5 
05/08/02 1 MP 50 6.3 0.4 2.9 
12/08/02 1 MP 19 2.1 0.3 2.2 
       
28/05/02 2 GU 10 1.7 0.2 1.6 
28/05/02 2 MP 10 4.7 0.4 2.2 
12/08/02 2 MP 30 6.1 0.5 3.3 
04/10/02 2 MP 40 2.7 0.3 2.1 
       
28/05/02 3 GU 10 1.8 0.1 1.0 
28/05/02 3 MP 10 3.6 0.4 2.6 














Long terms precision: Machine reliability over duration of study 
 The long term stability of BUA and SOS was monitored by recording the QAB and QAS. 
According to Hologic, over several months, typical mean values fluctuate within the 
following range: Mean QAB = 0 .93 - 1.07 and Mean QAS = 0.993 - 1.007 (Hologic, 
1998). It is recommended that if QAS and QAB results are beyond these limits for more 
than two weeks, the unit should be re-calibrated. 
Figures 1 and 2 show monthly means for QAB and QAS for the duration of the study. 
Months corresponding to winter months are indicated by the blue arrows below the x- axis. 
In general, both machines showed similar fluctuations for QAB over the course of the 
study. QAS readings were relatively stable for the first two years of the study where after 
there were wider fluctuations and readings for the MP machine drifted towards the lower 
end of acceptable range. Recalibration procedures were followed and transducer pads were 
changed in month 13 and 27 for the GU machine, and in month 9 and 19 for the MP 
machine. Services were performed in month 23 on the GU Machine and in months 9 and 22 
on the MP machine. There was no obvious seasonal drift in QAB or QAS corresponding to 
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5.5. Comparisons between QUS machines: 
 
Table 10: BUA and SOS differences for the two Sahara machines.  
 





BUA(MP) – BUA(GU) 146 0.4 5.35 -23.3 11.9 
SOS (MP) – SOS (GU) 146 3.3 9.67 -30.9 35 
 
Table 10  shows pooled results of  measurements on 48 to 50 different subjects  by a single 
operator performed  at annual intervals - on October 2003 (N=50), October 2004  (N=48) 
and October 2005 (N=48). The MP machine read slightly higher for both BUA and for SOS 
than the GU machine.  In the case of BUA, this difference was not significant (t = 0.8233, p 
= 0.412). For SOS however, the difference between the two machines was highly 
significant  (t = 4.139, p=0.000) 
 
5.6. Agreement between QUS and DEXA: Small study   
Results for the small study (N=14) comparing DEXA BMD at different hip sites and at the  
lumbar spine with  Sahara  QUS results from both machines are shown in Table 11. 
Table 11: Correlation coefficients for QUS and DEXA 
 
 GU 
BUA   
GU 




BUA   
MP 




Fem neck  
0.69 0.65 0.68 0.72 0.61 0.67 
DEXA:Fem 
Trochanter 
0.78 0.84 0.84 0.77 0.82 0.83 
DEXA: Fem  
Total hip 
0.74 0.73 0.75 0.74 0.70 0.74 
DEXA: 
L1-l4 
0.60 0.54 0.58 0.53 0.49 0.52 
 
 
For the Gugulethu sonometer, all the correlation coefficients were significant at p<0.05). 
For the Mitchell’s Plain sonometer the correlation coefficients were also significant 











Bland-Altman analysis of agreement 
Although  commonly used, Pearson’s correlation coefficient can be misleading in 
measuring agreement (Bland and Altman, 1986). The correlation coefficient measures the 
strength of relation between two variables, and perfect correlation occurs (r =1) if the points 
lie along any straight line. For perfect agreement between 2 variables, the points must lie 
along the line of equality. In addition, the correlation coefficient is affected by the range of 
the response but it is not influenced by the scale of the measurement. For these reasons, the 
Bland-Altman method offers a more accurate approach for analyzing agreement between 
two different methods measuring the same quantity (Bland and Altman, l986).  
We used the Bland-Altman approach for comparison of BMD between the two QUS 
machines and between each QUS machine and DEXA (see Table 12) 
Table 12: Bland Altman statistics for agreement between QUS devices and DEXA. (N=14) 
 
 
Comparing results for the two QUS machines shows again that  the MP machine was 
reading slightly higher than the GU machine for  mean BMD for these subjects. However, 
the 95% Confidence Interval (CI) overlaps zero. When QUS is compared with DEXA, both 
QUS machines showed similar lower means for calcaneal BMD  than  mean BMD as 
measured by DEXA at the femoral neck. For both QUS machines, these differences are 
significant  (95% CIs  do not overlap zero).  The Limits of agreement are estimates from 
the data (Mean difference  ± 2SD)  that can be applied to the population in general when 
 Mean 
Difference 
      95% CI    Limits of agreement 
(Mean diff ± 2SD) 
BMD (GU) and BMD 
(MP)   
-0.008 -0.025 ; 0.009 -0.066 ;  0.051 
BMD (MP) and DEXA  at  
Fem neck 
-0.281 -0.338 ; -0.224 -0.477 ;  -0.085 
 
BMD (GU) and DEXA  at  
Fem neck 











comparing the two methods. If these limits are beyond what is clinically acceptable, the two 
methods are not interchangeable. The limits of agreement of the two QUS BMD 
measurements with the DEXA BMD are similar for both machines. The range of these 
limits is 0.392g/cm
2 
  (Lower limit; Upper limit -0.477; -0.085) for the MP machine  and 
0.385g/cm
2
 (Lower limit; Upper limit  -0.466; -0.081) for the GU machine. The Standard 




shown in Table 12). For both machines the range encompassed by the limits of agreement 
is more than 3 SDs of the DEXA measurement, suggesting that the two methods do not 
agree sufficiently to be used interchangeably.    
Bland-Altman plots allow for graphical representation of any trend in variance and should 
be interpreted visually and not by means of analysis.  Figures 3 and 4  plot  the differences 
between QUS and DEXA for BMD against the average for the two methods for each 
machine respectively. These graphs show no relationship between the size of the 
measurement and the size of the variance, nor is there a trend in the variance that relates to 











































































6  DISCUSSION   
6.1 Risk factor Associations 
Our results showed that age, BMI, height, early  physical activity  as well as  age at 
menarche and parity were  associated with either BUA, SOS or QUI individually or with 
more than one of these ultrasound measures.  Except for BMI in women of mixed race, the 
associations of these variables with QUI were the same as with SOS. There were 
differences between our two populations for associations of QUS measures with age at 
menarche and with primary school physical activity. Stratified analyses according to 
categories of BMI did not resolve these differences.  Nor did this approach alter the inverse 
association of QUS measures with height. The effect of depot contraceptive progestins on 
bone health was evaluated in our original study and lower bone mass in current users was 
confirmed (Rosenberg et al., 2007). 
The associated factors found in our study  are similar to those known to be consistently 
associated with BMD as measured by DEXA in premenopausal women according to a 
review by Tudor-Locke and McColl (2000). In this review associations with BMD included 
age, BMI, age at menarche, smoking, load bearing exercise and use of depot contraceptive 
progestins. Additional factors reported to be associated with BMD that our study did not 
assess are as follows: Use of calcium supplementation where dietary intake is low, Vitamin 
D levels, primary amenorrhea, and family history of osteoporosis. 
Associations with individual risk factors: 
The following section examines the QUS associations for the individual risk factors in our 











DEXA. Our QUS findings are then compared with QUS findings reported in the literature 
for premenopausal women from other populations. 
Age 
In our study QUS measures increased with increasing age in black women up to 44 years  
whereas in women of mixed race these measures  increased up to 39 years and then 
decreased in the oldest age category. This decrease in our mixed race women of 40 years 
and older suggests the onset of bone loss in late premenopausal years. As this apparent 
drop-off of QUS values after 40 years was not present in our black women and since BMI 
is highest in the oldest category of black women, their continued increase in QUS with age 
may be due to a protective effect of BMI which was unresolved in our analysis. 
The onset of bone loss just prior to menopause has been shown in DEXA studies where it is  
generally reported that peak BMD at the femoral neck had occurred by 20 years of age, 
where after it remained stable until the perimenopausal years when it began to drop. In 
comparison, total body BMD showed continuous small increments with age (Khan and 
Syed, 2004) possibly due to continued  periosteal apposition at  the vertebral bodies,  with 
the onset of loss occurring in the late premenopausal  or in the perimenopausal years. 
(Tudor-Locke and McColl 2000).    
Minor population differences in the association of bone mass and age may stem from both 
genetic as well as environmental factors such as physical activity and nutrition 
(Micklesfield et al., 2005). QUS studies on pre- and post-menopausal European (Adami et 
al., 2004, Langton and Langton, 1997) and Asian women (Vu et al., 2005) have shown an 
increase of both SOS and BUA up to fourth decade followed by a significant decrease  after 











QUS with age (Gregg et al 1999).This may be due to the relative stability of bone mass 
prior to menopause as it is generally accepted that the rapid age-related loss of bone with 
accompanying osteopeania is most apparent in the immediate post-menopausal phase 
(Gregg et al., 1997). Alternatively it may simply reflect the preponderance of cross 
sectional over the more appropriate prospective QUS studies.   
Body Mass Index   
Increased BUA, SOS and QUI with increasing BMI was found in our study in black 
women.  BUA, to a lesser extent QUI, but not SOS increased in mixed race women. We 
therefore interpret these results cautiously as supporting a general positive association 
between BMI and QUS measures. BMI has demonstrated a consistent positive relationship 
with bone mineral measurements by DEXA (Tudor-Locke and McColl 2000).    
Positive associations of  BUA and SOS with  BMI  have been demonstrated in different 
premenopausal populations including European women (Babaroutsi et al., 2005, Kroke et 
al., 2000),  Arabian women (Saadi et al.,  2003) and White and African- Americans (Gregg 
et al., 1999 Gregg et al., 1997). However, as with SOS in our mixed race women, not all 
studies have demonstrated this relationship. The multicentre European OPUS study 
(Stewart et al., 2006) the ESOPO study on Italian women (Adami et al., 2004) and studies 
on Turkish women (Gemalgez et al.,  2007) did not report the association of QUS measures 
with BMI  as significant.  In these studies weight rather than BMI was associated with 
some but not all QUS measures. These inconsistencies are hard to rationalize, but it is  
possible they stem from  variation  in body composition. Since the main association of 
body mass with QUS measures is due to lean body mass rather than fat mass (Kroke et al.,  











unequally, the association of weight or BMI with QUS measures could be expected to be 
somewhat inconsistent.  
Height. 
 In both our study groups, height was negatively related to SOS and QUI but there was no 
association with BUA. As an increase in height is usually accompanied by a concomitant 
increase in weight and therefore increased mechanical loading on weight-bearing bones, 
positive associations with bone mass are to be expected. We surmised that as our taller 
women in both study groups had a significantly lower BMI than our shorter women (results 
not shown) this may account for the decrease in SOS.  However, when analyzed in three 
separate BMI strata, the negative association of height with SOS and QUI measures 
remained for both study groups in both the lighter and the heavier BMI categories. 
 For BMD measured by DEXA, height has been demonstrated to be positively and 
significantly related to BMD at the femoral neck, but not at the lumbar spine (Mazess and 
Barden 1991).  
A negative association with estimated BMD from QUS measures was demonstrated in 
South East Asian women in the United States (Lauderdale, 2001). In contrast, among Asian 
premenopausal women (Vu et al., 2005) increased height was associated with increased 
SOS, but not with change in BUA, while other studies have shown positive associations 
between height and both BUA and SOS (Gregg et al., 1997). 
Age at  menarche 
 The association of increased QUS measures with earlier onset of menarche was 











no trend in association between age of menarche and QUS measures and further stratified 
analysis according to three BMI strata did not alter this.  
A number of cross sectional DEXA studies of premenopausal women demonstrated a 
similar inverse relationship with age at menarche (Tudor-Locke and McColl 2000), 
although these authors did caution that these effects may not generalize to all populations. 
Increased bone mass associated with early onset of menarche may be attributed to the 
trophic effect on bone due to longer exposure to estrogens, however it can also happen   
that a later age at menarche is the result of underlying and unreported hormonal 
irregularities. In these cases bone mineral would be directly influenced to a greater extent 
than would otherwise occur in the normal hormonal environment.   
In some of the European studies (Babaroutsi et al., 2005)  the inverse association with  age 
at menarche was present for  all 3 QUS measures, while other  European and Saudi Arabian  
studies  showed associations with BUA but not with  SOS and  QUI (Adami et al., 2004,  
Saardi et al., 2003). In Asian Americans (Lauderdale et al., 2001) no relationship was 
present.   
Parity 
Our mixed-race parous women had lower BUA, SOS and QUI values than nulliparous 
women. For parous black participants SOS and QUI were lower but not BUA. There is 
currently no consistent reported evidence that parity is associated with reduced BMD as 
measured by DEXA (Tudor-Locke and McColl 2000).   
During pregnancy estrogen levels rise, and then decrease postpartum and during prolonged  











with numbers of pregnancies. These variations will affect BMD accordingly (Karlsson et 
al., 2001).  
In other QUS studies, some have demonstrated inverse associations of parity with QUI 
(Adami et al., 2004), while others have shown similar inverse associations with SOS but 
not with BUA (Vu  et al.,  2005, Saardi et al., 2003).   
Physical Activity 
Our study demonstrated a positive association for primary school physical activity 
measured in total impact hours with QUS measures in mixed race but not in black women. 
The benefits of current high impact endurance activities on BMD determined by DEXA 
have been repeatedly demonstrated (Tudor-Locke and McColl 2000), but the evidence for 
associations between BMD and historical activity is inconclusive.  
Historical physical activity is notoriously difficult to capture accurately due to difficulty 
with recall. Difficulties in cross sectional studies also stem from indistinct definitions of 
current versus historical activity as well as the use of a plethora of different methods for 
quantifying physical activity.  The instrument used to quantify and evaluate historic 
physical activity in a study population needs to be appropriate to the environment of the 
participants. Our study reported on a specific range of physical activities during primary 
school years in an attempt to quantify historical activity in a defined and accurate way. In 
this, we were guided by a previous study of South African black and mixed race women, 
where the physical activities shown to be most strongly associated with BMD were 
walking, walking with loads and sport activities (Micklesfield et al., 2003). Despite much 
higher levels of primary school physical activity in our black women than in our mixed race 











The positive effect of current physical activity on BUA and SOS has been demonstrated in 
South African white women (Micklesfield et al., 2005) and premenopausal European, 
Asian and American women (Barabroutsi et al., 2005, Vu et al., 2005, Gregg et al., 1999, 
1997). However, for historic physical activity some  researchers have shown a relationship 
with  QUS measures (Vu et al.,  2005, Adami et al., 2004 Micklesfield et al., 2003), while 
others have  not (Micklesfield et al., 2005). 
Education 
In our study we found no association of QUS measures with education level in either study 
group. Similarly, most DEXA studies found associations with educational levels to be 
either weak or absent (Alver et al., 2007).  
Educational level is an imperfect measure for socio economic status, however it is often a 
good predictor for chronic diseases known to be associated with poverty. Unfortunately 
DEXA studies addressing the association between BMD and socioeconomic status tend to 
be limited to postmenopausal women or to have small and biased samples (Alver et al., 
2007).  Despite these limitations there is some evidence for lower BMD in populations of 
low socioeconomic status (Gur et al., 2004).  
Most reports failed to show an association of QUS bone measures with educational level 
with the exception of a study on Vietnamese women in which a lower educational level was 
associated with reduced SOS (Vu et al., 2005).  
Calcium Intake 
As with education, we found no association of QUS measures with calcium intake in either 
study group. Some cross sectional DEXA studies have  suggested a small consistent 











younger women, particularly among those whose calcium  intake is low (Tudor-Locke & 
McColl 2000). In QUS studies, the associations have been inconsistent (Stewart A, 2006, 
Barbaroutsi et al., 2005, Adami et al., 2004).  
Alcohol Intake 
As with education and calcium intake, we found no association of QUS measures with 
alcohol intake in either study group. 
DEXA studies have shown no association or negative associations of moderate alcohol 
consumption patterns with BMD (Tudor-Locke & McColl 2000). In the case of alcoholism, 
the adverse impact on bone is well documented and reported to be severe, however at the 
opposite extreme, a small alcohol intake has been shown in some studies to be protective 
for BMD as compared with nondrinkers (Bainbridge et al., 2004). This effect is illustrated 
in the well-documented, although controversial, “j-shaped” curve for association between 
alcohol intake and chronic disease (Connor J, 2006). 
The majority of QUS studies in other populations have been inconclusive in demonstrating 
any consistent effect of alcohol drinking intake on bone health (Gregg et al., 1999, 1997).  
Smoking 
Our results suggest that mixed race women smokers have a lower SOS than non- smokers 
but there was no association evident with any of the QUS measures for non-smokers, ex 
smokers and current smokers of cigarettes in  black women. The prevalence of ever-
smokers in the mixed race women was high (68%), however the numbers of cigarettes 
smoked and numbers of smoking years was relatively low  thus generating  a limited range 
of response for  evaluation of a possible association.  Prevalence of ever-smokers among 











the steroid hormonal environment, but again reviews in literature are inconsistent as to how 
reliable the evidence is for this effect. Tudor Locke (2000) argues that there is sufficient 
evidence to support an association with BMD measured by DEXA.  
The  ESOPO QUS study (Adami et al., 2004) found an adverse effect of smoking on 
Ultrasound QUI., however a  recent meta-analysis (In Babaroutsi et al., 2005) showed no 
consistent effect of smoking on QUS measures. This is generally supported in other reports 
(Micklesfield et al.,  2005,  Adami et al., 2004,  Gregg et al., 1999). Specifically, no 
association was demonstrated in American premenopausal women (Gregg et al., 1999), nor 
in Europeans (Kroke et al., 2000).   
 6.2  Strength of association with risk factors.  
Our analysis is restricted to premenopausal women as a result of the aim of the original 
study which was to evaluate the effects of injectable contraceptive use on bone mass.   
Studies  comparing pre- and post menopausal women have repeatedly demonstrated the less 
obvious  relationship between risk factors and QUS measurements in younger women in 
whom  only a small number of measured risk factors showed association (Stewart A, 2006 
Saadi et al., 2003, Kroke et al., 2000). In comparison, postmenopausal bone loss was 
accelerated and early or cumulative life-style influences tended to make their appearance 
more obvious during this process.  
6.3 Normative data for black and mixed race women  
There are no previous studies describing QUS measures for black and mixed race 
premenopausal  women in South Africa. Comparative data for factors related to QUS 
measures in South African  women are limited to a study of  187  white women 











age and current physical activity, but not with  parity, calcium intake, smoking or alcohol 
use.  
Our age-adjusted means for black and mixed race women were derived from a sufficiently 
large sample to be considered as reliable normative data for premenopausal women from 
these populations (Tables 6 and 7). We considered the two study groups separately as both 
the risk factor distributions and the adjusted QUS outcomes were significantly different. In 
addition, our study was not designed specifically to assess ethnic differences as different 
Sahara machines were used at the two sites. Nonetheless population comparisons are made 
in the public health literature and the plea for population specific databases for QUS 
measures is often heard (Krieg M-A et al., 2008, Gluer, 2006, Hough, 2003).  
In order to compare our results for black and mixed race women, it is necessary to bear in 
mind that  different QUS machines were used for each group. We measured differences 
between the two machines on three occasions in the course of our study, and analysis of 
this combined data showed no significant differences between the two machines for BUA, 
but significantly higher SOS readings for the device used for mixed race women. We 
therefore conclude that the lower adjusted means in every age category for BUA in our 
mixed race women suggested that these women do indeed have a marginally lower bone 
mass than their black counterparts. The similar lower results in the majority of categories 
for SOS supported this.      
Differences for ethnic groups in BMD and in the strength of association between QUS and 
various risk factors have been reported elsewhere. Thus South African black and mixed- 











(Micklesfield et al., 2004), and African–American women aged 45 -53   had a substantially 
higher SOS, but no difference in BUA, than white women (Gregg et al., 1999). 
Whether or not ethnic differences are based on genetic or lifestyle differences or on 
investigator bias, additional normative data on population- specific QUS values and 
comparative QUS associations are needed. These will assist in evaluating QUS as a clinical 
tool and as a useful instrument in epidemiological studies, particularly in resource- poor 
settings where DEXA is not accessible.  
6.4 QUS and DEXA measures: The question of validity 
 In our small study on 14 individuals in which we measured BMD using DEXA, the 
correlation coefficient for femoral neck and lumbar spine was 0.78 and for total hip and 
lumbar spine it was 0.88.  In other DEXA studies, the between site correlation for spine and 
hip BMD is reported to be in the region of 0.77. (Gluer and Hans, 1999) This correlation 
increased in studies on excised bone specimens (r=0.9, Gluer 2006). 
We also compared DEXA to QUS measures and showed a lower correlation between 
lumbar spine BMD and QUS mea ures than between hip BMD and QUS.   Similar lower 
correlations between lumbar spine DEXA and QUS as compared to femoral neck 
measurements is reported frequently (Krieg et al., 2008). 
In other studies the magnitude of the correlation coefficient for ultrasonically derived 
measurement of bone mineral density (BMD) at the calcaneum, and spinal or hip  BMD as 
measured by DEXA has ranged from  0.29 to  0.88 (Prins et al., 1998). This variation 
stemmed in part from intra- individual variation due to varying BMD at different 
anatomical sites, as well as from differences between the two methods of measurement.  











and QUS (Reproducibility error = 2.5 – 3.5 % (WHO, 1994) and therefore were 
compounded in comparative studies; these could explain the modest correlation between 
the two measurement techniques (Gluer, 2006). Further differences could be explained by 
the QUS measurement itself as QUS measures other elements of bone strength related to 
trabecular architecture and structural anisotropy, that are not dependent on BMD (Gluer 
2006, Bauer et al.,1997). 
Notwithstanding all the reports of varying strengths of correlation, it is the measure of 
agreement rather that dictates whether or not two measurement methods can be used 
interchangeably. As noted earlier the ISCD has an official position on this matter that is 
revised annually according to the most recent evidence (International Society for Clinical 
densitometry, 2008). From our study results, the Bland Altman analyses confirmed that 
QUS and DEXA methodologies are not sufficiently in agreement to be substituted for each 
other.  
6.5 Short and Long Term precision    
Short term precision.  
Our tests of repeated measurements on a single individual by 1 operator on the same 
machine reflected operator technical expertise and machine stability, given that the ambient 
temperature and soft tissue properties over the course of the trial (approximately two hours) 
were stable. These trails replicate the method used by Hologic to generate their product 
specifications (Hologic Users guide 1998) and narrow the source of variability down to 
operator technique and machine function.  The mean and range for coefficients of variation 
from 6 other studies reporting  precision for the Sahara machine are  4.1% (2.7-5.0) for 











Following training, our precision error was within these ranges. These results ensured that 
we could assume operator proficiency of an international standard and that the Ultrasound 
devices were in full working order at the start of the study.  
Long  term precision 
For the two Sahara machines used in the study, QC was performed on a daily basis and 
monthly means and standard deviations were monitored for long term trends. Transducer 
pads were changed when necessary and recalibration was performed when readings were 
consistently on the low or high side. We felt assured that the built in QC safety limits 
combined with our monitoring processes ensured a sufficient level of precision to be 
confident of the quality of our study results. 
6.6 Strengths and Limitations of the study 
The major strength of this study was the large sample size. This allowed for efficient 
statistical power in the multivariable analyses. In addition, little interviewer and machine 
variability and careful QC monitoring contributed to high levels of precision in the study. 
Limitations were that we were not able to carry out DEXA measurements on our study 
subjects to confirm our results due to distance from study centers with a DEXA machine 
and the expense that this would have incurred. Another limitation is the lack of age data for 
the various school epochs that we used to classify periods of physical activity. Since bone 
responses to physical activity are greatest during the growth phase, and as the age during 
which our participants attended primary school was very variable, information on age on 
finishing primary school might have been useful by  allowing us to  link historical physical 











7. CONCLUSION   
This study examined QUS measures in a large population of South African black and 
mixed race premenopausal women in relation to known risk factors for BMD as measured 
by DEXA. For the most part, associations with risk factors were similar for both study 
groups. However black women had higher QUS values after adjusting for confounders than 
mixed race women, and there were differences between the study groups for the 
associations of QUS measures with age at menarche and with primary school physical 
activity. In general, however, we demonstrated that measures in this study had similar 
associations to those shown in DEXA studies on premenopausal  women, and to those 
reported in QUS studies in other populations.  
As all women in our study were premenopausal and less than 44 years old the rapid age 
related bone loss associated with menopause had not commenced, the strength of 
association with the risk factors was moderate. QUS measures slightly different qualities of 
bone than does DEXA and further studies comparing its associations with risk factors to 
those associated with DEXA measures will increase the usefulness of this highly portable 
and easily accessible device. DEXA is the more precise instrument, yet in resource-poor 
settings where cost and logistical difficulties preclude any such studies from being carried 
out, QUS may be considered a suitable tool to assess bone quality in large epidemiological 
studies. However it is well noted that QUS may not be used for monitoring bone status in 
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Control for age,  education, age at menarche, number of live births, cigarettes smoking, alcohol use, calcium 









BMI Height N BUA SOS QUI N BUA SOS QUI 
< 25 < 153 317 76.5     1567 102. 52 75.5 1570 102.9     
 153 – 157 235 74.8 1561 99.8 85 75.8 1561 100.2 
 158  – 161 208 74.9 1557 98.2 136 78.0 1561 101.0 
   162+  141 75.2 1557 98.2 183 77.0 1559 99.9 
 P for trend  0.237 0.000 0.001  0.404 0.055 0.278   
          
25-29 < 153 204 77.6     1561 101.0 73 78.0 1566     102.9 
 153 – 157 135 79.0 1559 100.8 138 81.9 1567 104.9 
 158  – 161 108 78.4 1558 99.6 151 80.0 1563 102.5 
   162+  60 79.6 1556 99.6 171 81.5 1559 101.8 
 P for trend  0.342 0.122 0.471  0.224 0.020 0.225 
          
>30 < 153 241 81.6 1566 104.5 86 83.8     1566 105.3 
 153 – 157 121 80.0 1557 100.0 163 86.3 1570 108.3 
 158  – 161 92 78.9 1552 97.7 179 84.4 1563 104.5 
   162+  33 77.9 1560 100.4 181 84.9 1563 104.5 
 P for trend  0.047 0.000 0.001  0.963 0.056   0.178 

















Control for age, BMI, height, education, age at menarche, number of live births, cigarettes smoking, alcohol 




























BMI Quartile of Primary 
school PA 
N BUA SOS QUI N BUA SOS QUI 
< 25 1  (0 - 310) 298  75.2 1561 99.7 61 74.5 1556 97.6 
 2 (311 – 1118) 288 75.3 1560 99.3 82 76.4 1562 101.1 
 3  (1119 – 2582) 244 75.1 1563 100.5 116 77.8 1560 100.7 
 4   (2583 – 31579) 71 78.4 1569 104.3 197 77.4 1562 101.3 
 P for trend  0.130 0.022 0.031  0.286 0.329 0.282 
          
25-29 1  (0 - 310) 179 77.3 1556 98.7 82 81.1 1565 104.1 
 2 (311 – 1118) 149 78.7 1561 101.8 93 81.9 1568 105.5 
 3  (1119 – 2582) 128 80.5 1562 102.7 134 79.0 1560 101.2 
 4   (2583 – 31579) 51 76.2 1559 99.4 225 81.0 1562 102.5 
 P for trend  0.940 0.378 0.556  0.892 0.156 0.236 
          
≥30 1  (0 - 310) 161 80.0 1560 101.2 93 82.2 1562 103.0 
 2 (311 – 1118) 165 79.4 1559 100.8 99 85.5 1565 105.6 
 3  (1119 – 2582) 111 81.7 1561 102.7 138 85.3 1566 106.2 
 4   (2583 – 31579) 50 82.7 1566 105.1 279 85.6 1566 106.2 
 P for trend  0.133 0.000 0.090  0.212 0.315 0.246 






















Control for age, BMI, height, education, number of live births, cigarettes smoking, alcohol use, 
calcium intake and physical activity.  
 
 




BMI Age at Menarche N BUA SOS QUI N BUA SOS QUI 
< 25 < 13 265 76.8 1564 101.8 37    78.7 1558 100.2 
 13 – 14  375 75.1 1560 99.6 162 77.4 1562 101.1 
 15 111 74.8 1561 99.8 96 76.8 1564 100.9 
 16+  150 74.5 1560 99.1 117 75.2 1557 98.1 
 P for trend  0.113 0.134 0.108  0.107 0.573 0.354 
          
25-
29 
< 13 149 78.4 1558 100.0 36 80.5 1561 102.1 
 13 – 14  199 78.8 1560 100.8 218 80.5 1564 103.3 
 15 68 76.9 1558 99.2 110 81.1 1563 103.0 
 16+  90 78.4 1561 101.3 139 81.2 1562 102.5 
 P for trend  0.985 0.393 0.562  0.665 0.689 0.895 
          
>30 < 13 177 81.1 1561 102.2 47 88.8 1576 111.6 
 13 – 14  197 79.6 1559 100.0 196 84.9 1566 105.8 
 15 52 81.8 1566 104.4 134 83.9 1565 105.0 
 16+  61 80.4 1559 101.1 173 84.0 1561 103.6 
 P for trend  0.728 0.617 0.633  0.05 0.003 0.003 
          
